AURA
Price
$6.42
Change
-$0.25 (-3.75%)
Updated
Jun 13 closing price
Capitalization
398.07M
54 days until earnings call
XNCR
Price
$9.19
Change
-$0.24 (-2.55%)
Updated
Jun 13 closing price
Capitalization
654.06M
45 days until earnings call
Interact to see
Advertisement

AURA vs XNCR

Header iconAURA vs XNCR Comparison
Open Charts AURA vs XNCRBanner chart's image
Aura Biosciences
Price$6.42
Change-$0.25 (-3.75%)
Volume$152.63K
Capitalization398.07M
Xencor
Price$9.19
Change-$0.24 (-2.55%)
Volume$421.64K
Capitalization654.06M
AURA vs XNCR Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. XNCR commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (AURA: $6.42 vs. XNCR: $9.19)
Brand notoriety: AURA and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 73% vs. XNCR: 44%
Market capitalization -- AURA: $398.07M vs. XNCR: $654.06M
AURA [@Biotechnology] is valued at $398.07M. XNCR’s [@Biotechnology] market capitalization is $654.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, AURA is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 6 TA indicator(s) are bullish while XNCR’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 6 bullish, 2 bearish.
  • XNCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AURA is a better buy in the short-term than XNCR.

Price Growth

AURA (@Biotechnology) experienced а -1.23% price change this week, while XNCR (@Biotechnology) price change was -4.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($654M) has a higher market cap than AURA($398M). AURA YTD gains are higher at: -21.898 vs. XNCR (-60.009). AURA has higher annual earnings (EBITDA): -101.63M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. AURA (128M). AURA has less debt than XNCR: AURA (18.4M) vs XNCR (67.8M). XNCR has higher revenues than AURA: XNCR (127M) vs AURA (0).
AURAXNCRAURA / XNCR
Capitalization398M654M61%
EBITDA-101.63M-161.68M63%
Gain YTD-21.898-60.00936%
P/E RatioN/AN/A-
Revenue0127M-
Total Cash128M470M27%
Total Debt18.4M67.8M27%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURAXNCR
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 18 days ago
76%
N/A
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SAOCX35.73N/A
N/A
NAA Opportunity Fund C
NIECX17.82-0.24
-1.33%
BNY Mellon International Equity C
NMCIX25.77-0.37
-1.42%
Voya MidCap Opportunities I
TSMGX15.63-0.23
-1.45%
Touchstone Sands Cptl Emerg Mkts Gr A
PLGIX16.87-0.27
-1.58%
Principal LargeCap Growth I Instl

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-3.75%
MGTX - AURA
53%
Loosely correlated
+0.61%
IDYA - AURA
50%
Loosely correlated
-0.45%
VRDN - AURA
49%
Loosely correlated
+1.34%
BEAM - AURA
49%
Loosely correlated
-2.18%
XNCR - AURA
47%
Loosely correlated
-2.55%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RCKT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-2.55%
RCKT - XNCR
59%
Loosely correlated
-4.56%
CRNX - XNCR
58%
Loosely correlated
-1.24%
BEAM - XNCR
57%
Loosely correlated
-2.18%
COGT - XNCR
56%
Loosely correlated
-1.94%
ERAS - XNCR
54%
Loosely correlated
-3.27%
More